MoneyWorks4Me

Lyka Labs - Quaterly Results

07 Feb 2023 Evaluate
The sales for the December 2022 quarter moved down -39.21% to Rs. 171.32 millions as compared to Rs. 281.82 millions during the year ago period.The Net Loss for the quarter ended December 2022 is Rs. -102.14 millions as compared to Net Profit of Rs. 56.79 millions of corresponding quarter ended December 2021Operating profit for the quarter ended December 2022 decreased to 33.33 millions as compared to 125.96 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 171.32 281.82 -39.21 611.37 1366.66 -55.27 1643.49 622.63 163.96
Other Income 11.14 6.73 65.53 28.37 20.60 37.72 27.20 22.10 23.08
PBIDT 33.33 125.96 -73.54 157.07 879.96 -82.15 1002.19 166.35 502.46
Interest 30.42 45.95 -33.80 87.57 170.12 -48.52 199.21 255.53 -22.04
PBDT -66.06 81.79 -180.77 -0.85 691.19 -100.12 756.30 -103.47 -830.94
Depreciation 33.25 21.18 56.99 101.94 62.58 62.90 153.89 80.50 91.17
PBT -99.31 60.61 -263.85 -102.79 628.61 -116.35 602.41 -183.97 -427.45
TAX 2.83 3.82 -25.92 0.04 77.25 -99.95 203.38 -39.36 -616.72
Deferred Tax -2.72 3.82 -171.20 -5.51 77.25 -107.13 203.38 -39.36 -616.72
PAT -102.14 56.79 -279.86 -102.83 551.36 -118.65 399.03 -144.61 -375.94
Equity 286.90 286.90 0.00 286.90 286.90 0.00 286.90 286.90 0.00
PBIDTM(%) 19.45 44.70 -56.47 25.69 64.39 -60.10 60.98 26.72 128.24
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..